Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA begins review of Ortec's CCS product for burn patients

April 6, 2001

MEDI-507 enters phase II evaluation in patients with psoriasis

April 4, 2001

Ortec seeks FDA approval to market wound-healing product in burn patients

April 3, 2001

Multivalent compounds claimed by P&G useful for hair loss, etc.

March 26, 2001

Chemokine receptor antagonists and their use described by SB (now GSK)

March 19, 2001

Schering prepares vitamin D derivatives with improved side effect and metabolic profile

March 14, 2001

Potential new treatment for dermatitis evaluated in animal models of contact hypersensitivity

March 14, 2001

EO-1428, a new aminobenzophenone for acne and other skin disorders

March 9, 2001

Clinical candidate for psoriasis Rx prepared in high yield at Roche

March 9, 2001

Vasogen receives approval in Canada to proceed with psoriasis trial

March 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...